A key value inflection point (KVIP) is a material de-risking event with the potential to drive significant NAV growth, for example by increasing the possibility of a realisation event such as M&A.
SIML's NAV Growth Framework aims to provide shareholders with more clarity on which milestones and what stage of the development cycle we anticipate our companies will be able to access capital and drive significant NAV growth, through M&A and liquidity events, in the current market environment.
At 30 September 2026, 92% of the Life Science Portfolio was in commercial, late-stage and clinical-stage companies. Syncona is funded to deliver all its KVIPs, with one expected by the end of CY2026, three before the end of CY2027 and one before the end of CY2028.
“This financial year has started with positive performance and strong momentum across the portfolio and sector. We believe there is a compelling opportunity ahead for significant value creation. I am particularly excited by the landmark clinical data from Beacon's pivotal study which offers hope for patients living with a devastating blinding condition.”